GeneDx Expects 2025 Revenues Of $350M-$360M Versus Consensus Of $338.782M

Benzinga
18 Feb

GeneDx Full Year 2025 Guidance

Management expects GeneDx to deliver full year 2025:

  • Revenues between $350 and $360 million and growth in exome/genome volume and revenue of at least 30%;
  • Adjusted gross margins between 65%-67%; and
  • Profitability with adjusted net income each quarter and for full year 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10